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2INTRODUCTION
Evidence from both human and rodent studies has indicated that alterations in
immunological parameters occur after space flight [1]. The number of flight experiments has
been small, and the full breadth of immunological alterations occurring after space flight
remains to be established. Among the major effects on immune responses after space flight that
have been reported are: alterations in lymphocyte blastogenesis and natural killer cell activity
[1-3], alterations in production of cytokines [4,5], changes in leukocyte sub-population
distribution [6], and decreases in the ability of bone marrow cells to respond to colony
stimulating factors [6]. Changes have been reported in immunological parameters of both
humans and rodents [1]. The significance of these alterations in relation to resistance to
infection remains to be established.
The objective of the studies contained in this project is to determine the effects of space
flight on immune responses of Rhesus monkeys. The hypothesis is that space flight and the
attendant period of microgravity will results in alteration of immunological parameters. The
parameters tested include: production of cytokines, composition of leukocyte subpopulations,
functional activities of immunologically significant cells, and differences in effects on cells
from primary and secondary lymphoid tissues. The expected significance of the work is a
determination of the range of immunological functions of the Rhesus monkey, a primate similar
in many ways to man, affected by space flight. Changes in immune responses that could yield
alterations in resistance to infection may be determined. The duration of alterations in immune
responses may also be determined. This could yield useful information for planning studies that
could contribute to crew health. Additional information on the nature of cellular interactions
for the generation of immune responses may also be obtained.
3METHODS
The methods used in thestudy have involved the determination of leukocyte
subpopulations and the production of cytokines. For the leukocyte subpopulation analysis, whole
blood was taken using EDTA as the anticoagulant or lymph node cells were harvested. Samples of
whole blood or lymph node cells were stained with the following monoclonal antibodies obtained
from the Becton-Dickinson Monoclonal Center, Mountain View, CA: Leu 2a, Leu 3a, Leu4, Leu
11a, Leu 12, Leu-M3, HLA-DR, IgG, and IL-2 receptor. Additional cells were stained with
monkey and IgM and Monkey anti-lgM (Fab')2. Control cells were either stained with a
monoclonal antibody directed against an irrelevant species or were unstained [7]. Cells were
then analyzed for fluorescence using a Coulter profile II flow cytometer [7].
For the cytokine production, samples of whole blood were placed on ficoll-hypaque
density gradients to purify mononuclear cells. The mononuclear cells or the lymph node cells
were treated with either phytohemagglutinin-P or polyribosinic-polyribocytidylic acid. After
the appropriate incubation period at 37oC, the culture supernatant fluids were harvested and
stored at -70oC [8]. The supernatant fluids were assayed by biological assay using vesicular
stomatitis virus and Hep-2 cells for interferon-alpha and -gamma production [8].
4RESULTS AND DISCUSSION
For the duration of this grant, we have been able to show the following:
1) We have been able to show that we can successfully collect blood, bone marrow and lymph
node from adult rhesus monkeys in space flight conditions.
2) We have been able to show that we can carry out the following assays on blood - leukocyte
subset analysis, interferon production and action, neutrophil activation.
3) We have been able to show that we can carry out the following assays on bone marrow cells
- leukocyte subset analysis, interferon production, effects of exogenous colony stimulating
factor GM on bone marrow cell colony formation
4) We have been able to show that we can carry out the following assays on lymph node cells -
leukocyte subset analysis, interferon production and action
5) The results described in sections 3, 4, and 5 indicate that we can carry out all procedures on
cells from adult rhesus monkeys as required for the space flight experiments originally laid out
in our Rhesus Project funding proposal.
6) We have carried out initial studies on looking for message for cytokines and cytokine
receptors on leukocytes, This is an additional refinement technique that will increase the power
of our proposed flight studies and is currently under development.
7) We have carried out a powers analysis to show statistically the chances of our obtaining
statistically significant data for our proposed flight studies
8) We have participated in the "SIT:" tests to determine the effects of the flight conditions
(outside of flight itself) on the immunological parameters we were planning to observe on flight
itself. We saw minimal effects on our immunological parameters.
9) We began participation in the "AART" tests to determine the effects of restraint on our
5immunologicalparameters.The dataare currentlyunderanalysisand resultswill be forwarded
to the technicalmonitoras theyare available.
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ABSTRACT
The ability of peripheral blood leukocytes to produce interferon-T (IFN-T) and be labeled with monoclonal
antibodies against cell-surface markers was determined in this study. Both peripheral blood leukocytes and
lymph node cells were able to produce IFN-T after challenge with mitogens. The rhesus monkey IFN-_/was
detectable by means of a biological assay but not by means of a radioimmunoassay for human IFN-_/.
Peripheral blood ieukocytes and lymph node cells from rhesus monkeys (Macaca mulatta) were treated with
fluoresceinated antibodies directed primarily against cell-surface antigens of humans. The degree of binding
was determined by means of flow cytometry. Several of the anti-human antibodies did bind to the rhesus
monkey peripheral blood leukocytes, as expected. In a novel study, the antibodies bound in a similar fashion to
rhesus monkey lymph node cells. Binding of the antibodies was equivalent whether the cells came from inguinal
or axillary lymph nodes. Rhesus monkey peripheral blood leukocytes incubated with recombinant human
IFN-_/showed enhanced expression of class II major histocompatibility complex antigens, as detected with
anti-HLA-DR antibodies.
INTRODUCTION
HE RHESUS MONKEY, Macaca mulatta, has been used as a
nonhuman primate model for immunological studies. <_-3)
Many human immunological reagents cross-react with rhesus
monkey tissue, allowing studies that can be carried out longitu-
dinally in situations in which human experimentation is not
accomplished easily. (_-3) This includes studies involving infec-
tious diseases such as the acquired immune deficiency syn-
drome (AIDS), _4) as well as studies involving space flight. (5)
In the present study, the ability of rhesus monkey peripheral
blood and lymph node cells to produce interferon-_/ (IFN-_/)
was determined, with optimum conditions for IFN-_/produc-
tion established. Although many studies have been carded out
showing cross-reactivity of many human reagents, most of
these studies have centered on analysis of peripheral blood cell
markers._2) In the present study, experiments were designed to
determine if leukocyte phenotyping studies could also be car-
ried out using lymph node cells from the monkeys. A compari-
son of fluorescein-conjugated antibody staining of peripheral
blood leukocytes with staining of lymph node cells was also
carried out. A determination of the ability of human IFN-',/to
cause increases in class II major histocompatibility complex
(MHC) antigen expression on both peripheral blood and lymph
node cells was carried out. In this fashion, techniques allowing
the use of the rhesus monkey as a surrogate for humans using
readily available human reagents were validated.
MATERIALS AND METHODS
Animals: Male, adult rhesus monkeys were bred at and ob-
tained originally from Charles River Laboratories (Key Lois
Island, FL). The monkeys were maintained at the NASA Ames
Research Center Animal Care Center (Moffett Field, CA). All
standard monkey health testing, including tuberculin and
herpes B virus testing, were carded out routinely. The vivarium
is AAALAC accredited, and all procedures were approved by
the Ames Research Center and the University of Louisville
_Department of Microbiology and Immunology, School of Medicine and Department of Biological and Biophysical Sciences, School of
Dentistry, University of Louisville, Louisville, KY 40292; 2Association Fran_aise de Lutte Contre la Mucovicosidose, F-75013 Paris C6dex,
France; 3Laboratoire Centrale d'Immunologie, Facult6 de Mddecine, CHU de Toulouse-Rangeuil, F-31054 Toulouse C6dex, France.
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animal care and use committees and carded out under the direct
supervision of a veterinarian. At the time of use, the monkeys
weighed from 8-15 kg.
Tissue Sampling: For blood sampling, the monkeys received
a dose of 10 mg/kg of Ketamine and were under anesthesia for a
time period of 45 min to 1 h. Blood was sampled from a vein
and collected into tubes containing sodium citrate as the antico-
agulant. For lymph node sampling, monkeys received a pre-
anesthetic dose of Telezol (10 mg/kg), followed by up to 2%
isofluorine with 1-2 liters/min of 02 during surgery. The total
time under anesthesia was approximately 2 h. One set of inguinal
and/or axillary lymph nodes was removed from each animal.
Induction and Assay of 1FN-_: IFN-',/ was induced by a
modification of the method of Kirchner et al. (6) for human
peripheral blood. Whole blood was diluted 1 : 10 with RPMI-
1640 medium without serum. One milliliter of the diluted blood
was added to a well on a 24-well tissue culture plate. Either 5
i_g of phytohemagglutinin-P or 5 Ixg of concanavatin A (Sigma
Chemical Co., St. Louis, MO) were added to each well and the
cultures were incubated at 37°C in 5% CO 2 for 48 h. At that
point, culture supernatant fluids were harvested and assayed for
IFN-_/ activity. For some blood samples, mononuclear cells
were separated .from whole blood by centrifugation on Ficoll-
Paque. (7) The mononuclear cells were resuspended in RPMI-
1640 medium with 10% fetal bovine serum at a concentration of
3 x 106/ml and then plated in 24-well tissue culture dishes. The
cultures were then induced to produce IFN-_/ as described
above. For lymph node cells, 3 x 10 6 cells were suspended in
RPMI-1640 medium with 10% fetal bovine serum, plated in
24-well tissue culture dishes, and then IFN-3, was induced as
described above. Some of the samples were tested for INF-_ in
a commercial radioimmunoassay (RIA) for human IFN--y (Cen-
tecor Laboratories, Malvern, PA). Other samples were assayed
by means of a cytotoxicity assay on HEP-2 cells using the
Indiana strain of vesicular stomatitis virus as the test virus.(8-1°)
The titer of IFN-'y was equal to the reciprocal of the last dilution
of test that decreased viral cytotoxicity by 50%. In this assay,
one unit of INF-'y was equal to 0.8 international standard units.
Leukocyte phenotype analysis: For blood cell staining, 40 p_l
of whole blood was placed in a microcentrifuge tube. For lymph
node cell staining, the lymph nodes were teased into individual
cells in RPMI-1640 medium with 10% fetal bovine serum
(GIBCO-Life Technologies, Inc., Grand Island, NY). The cells
were adjusted to a concentration of 1 x 10V/ml and 100 I,zl
placed in a microcentrifuge tube. The cells were washed once in
FTA buffer (BBL Microbiology Systems, Cockeysville, MD)
with 0.1% sodium azide and resuspended in residual buffer.
The following fluorescein-conjugated antibodies against leuko-
cyte cell-surface markers were purchased from Becton-Dicken-
son Immunocytometry Systems, San Jose, CA: anti-Leu 2a-
CD8; anti-Leu 3a-CD4; anti-Leu 4-CD3; anti-Leu 7_D57;
anti-Leu l la_2D16; anti-Leu 12-CD19; anti-Leu 14-CD22;
anti-Leu M1-CD15; anti-Leu M3-CD14; anti-HLA-DR; anti-
IL2R; anti-human IgM (purchased from Sigma Chemical Co.,
St. Louis, MO); anti-monkey IgG (purchased from Organon
Teknika Corp., W. Chester, PA); F(ab') 2 fragment of anti-
monkey IgG (purchased from Organon Teknika Corp., W.
Chester, PA); fluorescein-conjugated goat anti-rabbit IgG (non-
specific staining control; purchased from Accurate Chemical
and Scientific, Westbury, NY). A negative control was per-
formed without antibodies needed.
Ten microliters of the appropriate antibody was added to
each cell suspension, and the cultures incubated at 4°C for 25
min to allow optimum staining. (_1) One milliliter of lysing
solution (8.26 grams of ammonium chloride, 1.00 grams potas-
sium bicarbonate, 37 mg of tetrasodium EDTA, brought to 1
liter with deionized water at pH 7.4) was added to each sample,
and the cells were allowed to incubate at room temperature for 6
min to lyse erythrocytes. The cells were then centrifugated at
1,000 x g for 1.5 min and then resuspended in 1 ml of FTA
buffer. Cells were again centrifuged and then fixed by resus-
pending in 0.5 ml of 1% paraformaldehyde. The cells were then
analyzed for fluorescence, an indicator of presence of the anti-
gen, with a FACSCAN flow cytometer (Becton-Dickinson Cy-
tometry Systems, San Jose, CA) with Consort 30 software or
with a Coulter Profile II flow cytometer (Coulter Electronics,
Hialeah, FL). Lymphocytic and monocytic regions were gated
on three-part differentials by use of forward versus side scatter
plots. Negative gates were set by use of unstained samples.
Fluorescein isothiocyanate fluorescence >530 nm was detected
with the 488-nm line of an argon ion laser for excitation.
Incubation of cells with 1FN-_I: Human recombinant IFN-_/
(lot N9001AX, sp. act., 1.8 x 107 units/mg protein) was a gift
of Dr. Christine Czarniecki (Genentech, Inc., S. San Francisco,
CA). Whole blood samples were diluted 1 : 10 with RPMI-1640
medium and plated in duplicate in 24-well tissue culture plates
(Falcon Plastics, Oxnard, CA). One-hundred units of IFN--,/
was added to each wells, and the cultures were incubated at
37°C in 5% CO 2 for 24 h. (12) The cultures were harvested by
scraping with a plastic cell scraper, and 100 I_1 of the cell
suspension was placed in a microcentrifuge tubes. Twenty mi-
croliters of the anti-HLA-DR antibody was added, and staining
carried out as described above.
RESULTS
Induction of lFN-_l
IFN-_ was inducible by phytohemagglutinin or concanavalin
A in both peripheral blood leukocytes and lymph node cells
(Tables 1 and 2). Each protocol was repeated at least two times,
and only the results from all monkeys of a representative exper-
iment using concanavalin A are shown. Stimulation of whole
blood with mitogens did not result in IFN-_/production. Pro-
duction was observed when ficoll-paque-purified mononuclear
cells were challenged with mitogen (Table 1). The IFN-_ was
not detectable by use of an RIA specific for human IFN-'y. The
IFN-',/ biological antiviral activity was detectable, however,
using an antiviral assay on human HEP-2 cells. Very low levels
of innate antiviral activity were detected in the culture superua-
tants from purified peripheral blood mononuclear cells and
lymph node cells not challenged with mitogen.
Fluorescein staining of peripheral blood leukocytes
Cells from over 30 monkeys were analyzed, and only repre-
sentative data are shown here. Staining of rhesus monkey pe-
,o
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TABLE 1. INDUCTION OF IFN-"/ IN RHESUS MONKEY PERIPHERAL BLOOD
LEUKOCYTES BY MITOGENS
IFN-7 Titer +- SD
Treatment n Assay (units/ml)
Whole blood 5 RIA None detectable
Whole blood + mitogen 5 RIA None detectable
Whole blood 5 Antiviral assay None detectable
Whole blood + mitogen 5 Antiviral assay None detectable
Mononuclear cells 4 RIA None detectable
Mononuclear cells + mitogen 4 RIA None detectable
Mononuclear cells 4 Antiviral assay 12 --- 13
Mononuclear cells + mitogen 4 Antiviral assay 1,205 -+ 602
ripheral blood leukocytes was observed with the following anti-
bodies: anti-Leu 2a, anti-Leu 3a, anti-Leu 1la, anti-HLA-DR,
anti-human IgM, anti-monkey IgG, and anti-monkey IgG
(Fab') 2 (Fig. 1). No appreciable levels of staining were ob-
served using goat anti-rabbit IgG or any of the other antibodies
directed against human leukocyte cell-surface antigens.
Fluorescein staining of lymph node cells
Cells from 5 monkeys were analyzed, and only representa-
tive data are shown here. Staining of the rhesus monkey lymph
node cells followed the same pattern as that observed with
peripheral blood leukocytes (Fig. 2), except all staining ap-
peared to be more intense than that observed with peripheral
blood leukocytes and the anti-Leu 4 also stained the lymph node
cells. There were no apparent differences in staining patterns of
cells from inguinal or axillary lymph nodes.
Induction of class H MHC antigen expression by
human IFN-_I
Cells from 11 monkeys were analyzed, and only representa-
tive data are shown. Peripheral blood leukocytes from rhesus
monkeys showed increased expression of class II MHC anti-
gens [RhLA-D(DR)] after overnight incubation with human
recombinant IFN-_/, as detected by use of an anti-HLA-DR
antibody (Fig. 3).
DISCUSSION
Studies involving immunological reagents developed for use
in humans have been carded out using rhesus monkey cells._ 1-3)
This can be of great advantage in allowing the use of the rhesus
monkey as a model for diseases or experimental situations in
which human experimentation would be difficult.
In the present study, the production of IFN-_/by both rhesus
monkey peripheral blood leukocytes and lymph node cells after
mitogenic challenge was also explored. Previous studies have
indicated that human and rhesus monkey IFNs are cross-reac-
tive. (13"14) However, in our hands, a commerical RIA kit for
human IFN-_/ could not be used for the detection of IFN-_/
produced by rhesus monkey leukocytes. This appears to indi-
cate that the monoclonal antibody used in the kit for detection of
human IFN-_/ was not cross-reactive with rhesus monkey
IFN--y. Therefore, the most reliable method for detection of
rhesus monkey IFN-_/appears to be a biological assay testing
cell culture supernatants for antiviral activity. Apparently, this
assay can be carded out conveniently using human HEP-2 or
other human cells as the target cell for the virus infection.
The whole blood culture technique used routinely for produc-
tion of human IFN-'y (6) does not appear to be effective for
production of rhesus monkey IFN-_/. The more cumbersome
technique involving purification of mononuclear cells from pe-
ripheral blood does, however, appear to be very effective for
the study of induction of IFN-'y by the rhesus monkey. Induc-
TABLE 2. INDUCTION OF IFN-"/IN RHESUS MONKEY LYMPH NODE CELLS BY MITOGENS
1FN-_I Titer + SD
Treatment n Assay (units/ ml )
Lymph node cells 4 RIA None detectable
Lymph node + mitogen 4 RIA None detectable
Lymph node cells 4 Antiviral assay 21 ± 32
Lymph node cells + mitogen 4 Antiviral assay 285 ± 216
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Fig. 1. Flnorescein staining of peripheral blood leukocytes. A. No stain. B. Anti-Leu 2a. C. Anti-Leu 3a. D. Anti-Leu 4. E.
Anti-Leu 1 la. F. Anti-HLA-DR. G. Anti-human IgM. H. Anti-monkey IgG. I. Anti-monkey IgG (Fab')2.
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Fig. 2. Fluorescein staining of lymph node cells. A. No stain. B. Anti-Leu 2a. C. Anti-Leu 3a. D. Anti-Leu 4. E. Anti-Leu 1 la.
F. Anti-HLA-DR. G. Anti-human IgM. H. Anti-monkey IgG. I. Anti-monkey IgG (Fab') 2.
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Fig. 3. Induction of class II MHC antigen expression by human IFN-_/. A. No treatment, no stain. B. Incubated with IFN-',/, no
stain. C. No treatment, anti-HLA-DR. D. Incubated with IFN-% anti-HLA-DR.
tion of IFN-_/by mitogens in rhesus monkey lymph node cell
cultures was carried out without difficulty. It should be noted,
that the IFN-_/could have been contaminated with other inter-
ferons, as it was not purified or characterized furtherJ '5)
The results of the current experiments also confirm that leu-
kocyte surface antigen analysis can be successfully carried out
using primarily antisera directed against human antigensJ 2) A
great number of cell-surface markers can be analyzed, but sev-
eral markers on rhesus monkey cells, including macrophage
markers, did not show a cross-reaction with antisera directed
against human antigens.
A novel result of the present study is we have also shown that
lymph node cells from rhesus monkeys can be analyzed for
leukocyte surface antigen expression using primarily antibodies
against human cell-surface markers. The range of antibodies
that could be used was similar to that found effective on periph-
eral blood leukocytes, except the lymph node cells appeared to
stain more intensely than the peripheral blood leukocytes.
In addition, we have demonstrated that human IFN-_/can be
used to enhance and study expression of class II [RhLA-D(DR)]
MHC antigens on the surface of rhesus monkey peripheral
blood leukocytes. The enhanced expression of the MHC anti-
gens after IFN-_/treatment of the leukocytes was readily detect-
able using an antibody directed against HLA-DR antigens, and
offer the potential of novel studies for antigen presentation.
The expansion of immunological assays that are achieved in the
rhesus monkey using immunological reagents that are designed
for use in humans can serve as a valuable research resource.
Since new, potentially expensive, reagents specific for rhesus
monkey antigens do not appear, on the whole, to require devel-
opment, immunological experiments using a close-to-human
surrogate such as the rhesus monkey can be carried out readily.
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